Daniel J. Anderson, Ph.D. appointed Chief Scientific Officer of Integrated Biosciences in Redwood City, California.
Integrated Biosciences, a California-based biotechnology firm, has appointed Dr. Daniel J. Anderson, Ph.D., as their new Chief Scientific Officer. Dr. Anderson will be in charge of overseeing the company's scientific strategy and pipeline development in the discovery of small-molecule therapeutics for age-related diseases. Prior to joining Integrated Biosciences, Dr. Anderson was associated with Eikon Thera. Dr. Anderson's appointment aims to strengthen the company's proprietary platform for research in synthetic biology, chemistry, and AI.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments